1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Waning infant pertussis during COVID-19 pandemic
(
- Contribution to journal › Article
-
Mark
Randomised controlled trial showed long-term efficacy, immunogenicity and safety of varicella vaccines in Norwegian and Swedish children
(
- Contribution to journal › Article
- 2020
-
Mark
Vitamin D status and cardiometabolic risk markers in young Swedish children : A double-blind randomized clinical trial comparing different doses of vitamin D supplements
(
- Contribution to journal › Article
- 2019
-
Mark
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine : 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial
(
- Contribution to journal › Article
- 2018
-
Mark
Vitamin D intervention and bone : A randomized clinical trial in fair- and dark-skinned children at northern latitudes
(
- Contribution to journal › Article
- 2017
-
Mark
Increased Vitamin D intake differentiated according to skin color is needed to meet requirements in young Swedish children during winter : A double-blind randomized clinical trial
(
- Contribution to journal › Article
- 2016
-
Mark
Serum Vitamin D Depends Less on Latitude Than on Skin Color and Dietary Intake During Early Winter in Northern Europe.
(
- Contribution to journal › Article
- 2015
-
Mark
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.
(
- Contribution to journal › Article
- 2013
-
Mark
13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial
(
- Contribution to journal › Article
- 2012
-
Mark
Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model
(
- Contribution to journal › Article